Tex. Gov't Code § 549.0303 · Subchapter G. DRUG UTILIZATION REVIEW BOARD
CONFLICTS OF INTEREST.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) A voting board member may not have a contractual relationship with, ownership interest in, or other conflict of interest with:
(1) a pharmaceutical manufacturer or labeler; or
(2) an entity the commission engages to assist in developing preferred drug lists or administering the Medicaid Drug Utilization Review Program.
(b) The executive commissioner may implement this section by:
(1) adopting rules that identify prohibited relationships and conflicts; or
(2) requiring the board to develop a conflict-of-interest policy that applies to the board.
Notes and commentary — not statutory text
History
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/GV/htm/GV.549.htm
- Text hash
- sha256 582337419edfda477530a7659a87f353b430fc3354a584ba3bad21616bfcebee
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.